Registration: will open at the end of January 2027
Abstracts: will open at the end of February 2027.

Dear Friends and Colleagues,

We are delighted to welcome you to the International Primary Immunodeficiencies Congress (IPIC2027), in Mallorca, Spain.
We are thrilled to bring together clinicians with an interest in primary immunodeficiencies (PIDs)/ inborn errors of immunity (IEI) alongside leading experts, patient organisation representatives, nurses, industry representatives and other key stakeholders.

IPIC has become a premier international congress focused on PID clinical care and distinguished by its unique patient-centred programme. With a truly global influence, the congress has earned its definite place and role in the PID clinical landscape. The CME-accredited clinical programme of IPIC is structured to complement other existing international and regional PID scientific meetings.

The IPIC2027 programme will feature prominent international experts in the field and aim to engage attendees in thought-provoking and interactive sessions. Key topics will include, among others:

• The use of AI tools to improve clinical management of immunodeficiencies
• Targeted therapies
• Discussion of complex persistent infections case studies
• Regional clinical breaking news
• The current status of gene therapies
• Management of hepatic manifestations in PIDs
• Secondary immunodeficiencies
• Transplantation challenges and successes
• Philosophical and ethical considerations to clinical boundaries in genomicsEthical considerations
• Clinical development of PIDs

IPIC’s remarkable success stems from is its unique, well-balanced scientific programme that is clinically oriented and shaped by insights from key PID stakeholders: doctors, patients and nurses.
Thank you for joining us. We wish you a fulfilling and enjoyable IPIC2027!
Your sincerely,

Martine Pergent Congress Organising Committee President
Nizar Mahlaoui Congress Scientific Committee President
Johan Prevot IPOPI Executive Director